Guggenheim Reiterates Buy on Summit Therapeutics, Maintains $40 Price Target
Guggenheim analyst Brad Canino reiterates Summit Therapeutics (NASDAQ:SMMT) with a Buy and maintains $40 price target.
Scotiabank Maintains Sector Outperform on Oracle, Raises Price Target to $360
Scotiabank analyst Patrick Colville maintains Oracle (NYSE:ORCL) with a Sector Outperform and raises the price target from $350 to $360.
JP Morgan Maintains Neutral on Herc Holdings, Raises Price Target to $140
JP Morgan analyst Tami Zakaria maintains Herc Holdings (NYSE:HRI) with a Neutral and raises the price target from $127 to $140.
CIBC Maintains Neutral on Royal Gold, Raises Price Target to $250
CIBC analyst Anita Soni maintains Royal Gold (NASDAQ:RGLD) with a Neutral and raises the price target from $225 to $250.
Barclays Maintains Equal-Weight on Lincoln National, Raises Price Target to $46
Barclays analyst Alex Scott maintains Lincoln National (NYSE:LNC) with a Equal-Weight and raises the price target from $42 to $46.
Needham Initiates Coverage On Red Cat Holdings with Buy Rating, Announces Price Target of $17
Needham analyst Austin Bohlig initiates coverage on Red Cat Holdings (NASDAQ:RCAT) with a Buy rating and announces Price Target of $17.
Morgan Stanley Upgrades Kraft Heinz to Equal-Weight, Raises Price Target to $29
Morgan Stanley analyst Megan Alexander upgrades Kraft Heinz (NASDAQ:KHC) from Underweight to Equal-Weight and raises the price target from $28 to $29.
Morgan Stanley Maintains Overweight on Elastic, Raises Price Target to $120
Morgan Stanley analyst Sanjit Singh maintains Elastic (NYSE:ESTC) with a Overweight and raises the price target from $115 to $120.
Asure Software Can Gain From Small Client Churn Of Bigger Rivals Like Adp, Paychex: Analyst
Barrington Research analyst Vincent A.
Ladenburg Thalmann Maintains Buy on Essential Props Realty, Lowers Price Target to $27
Ladenburg Thalmann analyst John Massocca maintains Essential Props Realty (NYSE:EPRT) with a Buy and lowers the price target from $28 to $27.